Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Telik, Inc. 

3165 Porter Drive

Palo Alto  California  94304  U.S.A.
Phone: 650-845-7700 Fax: 650-845-7800



Drug Discovery

 Company News
Mintz Levin Represents San Diego-Based MabVax Therapeutics, Inc. In IPO Through Merger With Telik, Inc. (TELK) 7/11/2014 9:27:42 AM
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014 9:53:19 AM
Telik, Inc. (TELK) Announces First Quarter 2014 Financial Results 5/16/2014 6:21:53 AM
Telik, Inc. (TELK) And MabVax Therapeutics, Inc. Announce Definitive Merger Agreement 5/13/2014 9:16:53 AM
Telik, Inc. (TELK) Announces Third Quarter 2013 Financial Results 11/13/2013 9:06:24 AM
Telik, Inc. (TELK) Announces Second Quarter 2013 Financial Results 8/12/2013 6:19:12 AM
Telik, Inc. (TELK) Announces First Quarter 2013 Financial Results 5/13/2013 6:24:52 AM
Telik, Inc. (TELK) Announces Fourth Quarter and 2012 Year End Financial Results and 2013 Financial Guidance 3/14/2013 9:52:17 AM
Telik, Inc. (TELK) Announces Preliminary Agreement on Design of Phase 3 Registration Trial of Telintra® in Low to Intermediate-1 Risk Myelodysplastic Syndrome 1/23/2013 8:53:40 AM
Telik, Inc. (TELK) Announces Orphan Designation of Telintra® for Treatment of Myelodysplastic Syndrome 1/14/2013 9:06:51 AM